Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05469204 · ClinicalTrials.gov registry record · Phase 4
Effect of Estrogen Treatment on Drug Metabolism and Transport
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT05469204: Completed Phase 4 study, sponsored by University of Washington.
NCT05469204 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 22 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05469204, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
This project will evaluate the effect of estrogen treatment on how other medications are processed by the body.
Primary Outcome
ratio of the area under of the plasma concentration time curve (AUC) of midazolam in the presence to absence of gender-affirming estradiol treatment.
Interventions
- DRUG Midazolam oral solution
- DRUG Digoxin Oral Tablet
- DRUG Acetaminophen Oral Tablet
- DRUG Midazolam Injectable Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2025-07-30 |
| Phase | Phase 4 |
What the finished NCT05469204 record still lists
NCT05469204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which Midazolam oral solution is the first listed.
NCT05469204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05469204 about?
NCT05469204 is a clinical study titled "Effect of Estrogen Treatment on Drug Metabolism and Transport". This project will evaluate the effect of estrogen treatment on how other medications are processed by the body.
What is the current status of trial NCT05469204?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2022-11-01. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT05469204?
The interventions under investigation include: Midazolam oral solution (DRUG), Digoxin Oral Tablet (DRUG), Acetaminophen Oral Tablet (DRUG), Midazolam Injectable Solution (DRUG).
Who is sponsoring clinical trial NCT05469204?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05469204's enrollment target sits among peer trials
22 1731st of 2000 higher than 259 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI